NETRIS Pharma R&D activity is based on the fundamental research results generated by the “Apoptosis, Cancer and Development” Laboratory.

NETRIS Pharma and the “Apoptosis, Cancer and Development” laboratory actively work together to :


new Dependence Receptors


their role in cancer

Bring proof of concept studies 

supporting the therapeutic strategy

Develop therapeutic antibodies

for preclinical and clinical evaluation

For access to most recent publications :